First Trust Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $512K | Sell |
17,307
-27,231
| -61% | -$805K | ﹤0.01% | 2260 |
|
|
2025
Q1 | $1.33M | Sell |
44,538
-85,153
| -66% | -$2.54M | ﹤0.01% | 1941 |
|
|
2024
Q4 | $3.72M | Sell |
129,691
-11,601
| -8% | -$332K | ﹤0.01% | 1528 |
|
|
2024
Q3 | $5.46M | Buy |
141,292
+18,321
| +15% | +$708K | 0.01% | 1294 |
|
|
2024
Q2 | $3.96M | Buy |
+122,971
| New | +$3.96M | ﹤0.01% | 1384 |
|
|
2023
Q3 | – | Sell |
-92,793
| Closed | -$1.99M | – | 2383 |
|
|
2023
Q2 | $1.99M | Buy |
92,793
+3,414
| +4% | +$73.4K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $2.14M | Buy |
89,379
+6,814
| +8% | +$163K | ﹤0.01% | 1665 |
|
|
2022
Q4 | $1.92M | Sell |
82,565
-7,573
| -8% | -$176K | ﹤0.01% | 1714 |
|
|
2022
Q3 | $1.44M | Buy |
90,138
+39,065
| +76% | +$626K | ﹤0.01% | 1848 |
|
|
2022
Q2 | $905K | Sell |
51,073
-2,362
| -4% | -$41.9K | ﹤0.01% | 2018 |
|
|
2022
Q1 | $1.09M | Sell |
53,435
-3,076
| -5% | -$62.6K | ﹤0.01% | 2020 |
|
|
2021
Q4 | $1.06M | Buy |
56,511
+5,841
| +12% | +$109K | ﹤0.01% | 2030 |
|
|
2021
Q3 | $1M | Buy |
+50,670
| New | +$1M | ﹤0.01% | 2037 |
|